Ear zap may calm bleeding and nausea in sinus surgery
NCT ID NCT06662422
First seen Aug 19, 2026 · Last updated Aug 20, 2026 · Updated 1 time
Summary
This study tests whether a small device worn on the ear, which gently stimulates a nerve linked to the body's calming system, can improve conditions during sinus surgery. Half of the participants will receive the active stimulation, while the other half gets a sham device. Researchers will measure bleeding during the operation and check for nausea or vomiting after surgery to see if the stimulation helps.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Transcutaneous auricular neurostimulation (tAN) via the Spark Biomedical Sparrow Ascent system, a wearable electrode placed on the ear
- What this could lead to
- If effective, this non-invasive ear stimulation could become a simple way to reduce bleeding during sinus surgery and ease post-operative nausea.
- What could go wrong
- This is a small, early-stage trial with only 20 participants, so results may not be conclusive. The device may not improve outcomes, and individual responses can vary.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
20 people
The number who actually took part.
- Started
-
Oct 2024
- Finished
-
Jun 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * ASA 1 and 2 * Presenting for elective FESS surgery Exclusion Criteria: * Anti-fibrinolytic use within 30 days of enrollment * Known or acquired coagulation disorders * Hypercoagulable state, including morbid obesity and active smoking * Pregnancy * Blood transfusion with 30 days of enrollment * History of epileptic seizures * Presence of device such as pacemaker, cochlear prosthesis, neurostimulator * Ear infection * Abnormal ear anatomy which inhibits application of device * Presence of other significant disease or disorder which under the discretion of the principal investigator could influence the results of the trial or the participant's ability to participate in the trial
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Functional endoscopic sinus surgery are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Mount Sinai Hospital
New York, New York, 10029, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simple infusion make sinus surgery safer and clearer?
- Ear stimulation may soothe Post-Surgery anal pain
- Heart surgery study aims to unravel platelet mysteries
- New imaging method could speed up diagnosis of blood clotting disorders
- New study tracks clotting risks after major aortic surgery
- Bean beverage may tame blood sugar and clotting after meals